Save your place

Sign in to WhoBought

Please try again later.

Cumberland Pharmaceuticals Inc. (CPIX) institutional ownership

Latest close $6.81 Jul 28, 2026
Market cap$53M 52-week range SectorHealthcare
Funds holding · Q1 2026
28
reported CPIX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
12 buyers · 16 sellers

Cumberland Pharmaceuticals Inc. (CPIX) price and institutional activity

Dates

Q1 2026

$0 bought by 12 investors
Marex Group PLCXtx Topco Ltd +10 more
$0 sold by 16 investors
Perceptive Advisors LLCMarshall Wace, LLP +14 more
Bought Sold Totals per quarter; hover a bar for the names.

Cumberland Pharmaceuticals Inc. (CPIX) institutional activity · 28

Investor Type Est. change Change Δ Own Date
Perceptive Advisors LLC · Reduced
Change −144K Date Q1 2026
Perceptive Advisors LLC Reduced· Q1 2026 −144K Q1 2026
Marshall Wace, LLP · Exited
Change −48K Δ Own −100.0% Date Q1 2026
Marshall Wace, LLP Exited· Q1 2026 −48K −100.0% Q1 2026
Marex Group PLC · New
Change +36K Date Q1 2026
Marex Group PLC New· Q1 2026 +36K Q1 2026
Heron Bay Capital Management · Exited
Change −29K Δ Own −100.0% Date Q1 2026
Heron Bay Capital Management Exited· Q1 2026 −29K −100.0% Q1 2026
Susquehanna International Group, LLP · Exited
Change −26K Δ Own −100.0% Date Q1 2026
Susquehanna International Group, LLP Exited· Q1 2026 −26K −100.0% Q1 2026
Xtx Topco Ltd · New
Change +24K Date Q1 2026
Xtx Topco Ltd New· Q1 2026 +24K Q1 2026
Arrowstreet Capital, Limited Partnership · New
Change +20K Date Q1 2026
Arrowstreet Capital, Limited Partnership New· Q1 2026 +20K Q1 2026
Jane Street Group, LLC · New
Change +15K Date Q1 2026
Jane Street Group, LLC New· Q1 2026 +15K Q1 2026
Bank of New York Mellon Corp · Reduced
Change −14K Date Q1 2026
Bank of New York Mellon Corp Reduced· Q1 2026 −14K Q1 2026
J. Goldman & Co LP · Reduced
Change −14K Date Q1 2026
J. Goldman & Co LP Reduced· Q1 2026 −14K Q1 2026
Two Sigma Investments, LP · Reduced
Change −13K Δ Own −54.7% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −13K −54.7% Q1 2026
UBS Group AG · Reduced
Change −10K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −10K Q1 2026
Geode · Added
Change +7K Date Q1 2026
Geode Added· Q1 2026 +7K Q1 2026
State Street · Added
Change +6K Date Q1 2026
State Street Added· Q1 2026 +6K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −5K −24.2% Q1 2026
Data through Q1 2026 · filed May 29, 2026
15 of 28

Famous investor activity in Cumberland Pharmaceuticals Inc. (CPIX)

Cumberland Pharmaceuticals Inc. (CPIX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Brown Martin S. Jr · Director Grant (A) $5K
Price $2.80 Qty 2K Owned 10K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Brown Martin S. Jr Director Grant (A) $2.80 2K $5K 10K Mar 18, 2026 Mar 20, 2026
Galante Joseph C. · Director Grant (A) $5K
Price $2.80 Qty 2K Owned 64K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Galante Joseph C. Director Grant (A) $2.80 2K $5K 64K Mar 18, 2026 Mar 20, 2026
Jones James · Director Grant (A) $5K
Price $2.80 Qty 2K Owned 47K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Jones James Director Grant (A) $2.80 2K $5K 47K Mar 18, 2026 Mar 20, 2026
Krogulski Kenneth · Director 2 operations $16K
Price $2.80 Qty 6K Owned 302K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Krogulski Kenneth Director 2 operations $2.80 6K $16K 302K Mar 18, 2026 Mar 20, 2026
Young Caroline · Director Grant (A) $5K
Price $2.80 Qty 2K Owned 35K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Young Caroline Director Grant (A) $2.80 2K $5K 35K Mar 18, 2026 Mar 20, 2026
Anthony Todd M. · Officer Grant (A) $8K
Price $2.80 Qty 3K Owned 21K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Anthony Todd M. Officer Grant (A) $2.80 3K $8K 21K Mar 18, 2026 Mar 20, 2026
Bitterman Chris T. · Officer Grant (A) $8K
Price $2.80 Qty 3K Owned 19K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Bitterman Chris T. Officer Grant (A) $2.80 3K $8K 19K Mar 18, 2026 Mar 20, 2026
Hamm John M. · Officer Grant (A) $8K
Price $2.80 Qty 3K Owned 18K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Hamm John M. Officer Grant (A) $2.80 3K $8K 18K Mar 18, 2026 Mar 20, 2026
Herman James L. · Officer Grant (A) $7K
Price $2.80 Qty 2K Owned 21K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Herman James L. Officer Grant (A) $2.80 2K $7K 21K Mar 18, 2026 Mar 20, 2026
Kazimi A. J. · Director, Officer, 10% Owner Grant (A) $280K
Price $2.80 Qty 100K Owned 568K Trade date Mar 18, 2026 Filed date Mar 20, 2026
Kazimi A. J. Director, Officer, 10% Owner Grant (A) $2.80 100K $280K 568K Mar 18, 2026 Mar 20, 2026
Kazimi A. J. · Director Tax withholding or exercise payment (F) -$18K
Price $3.06 Qty -6K Owned 5.7M Trade date Mar 16, 2026 Filed date Mar 18, 2026
Kazimi A. J. Director Tax withholding or exercise payment (F) $3.06 -6K -$18K 5.7M Mar 16, 2026 Mar 18, 2026
Young Caroline · Director Other Form 4 events $20
Price $3.91 Qty 5 Owned 33K Trade date Dec 31, 2025 Filed date Jan 6, 2026
Young Caroline Director Other Form 4 events $3.91 5 $20 33K Dec 31, 2025 Jan 6, 2026
Jones James · Director Other Form 4 events $27
Price $3.91 Qty 7 Owned 45K Trade date Dec 31, 2025 Filed date Jan 6, 2026
Jones James Director Other Form 4 events $3.91 7 $27 45K Dec 31, 2025 Jan 6, 2026
Kazimi A. J. · Director, Officer, 10% Owner Other Form 4 events $27
Price $3.91 Qty 7 Owned 5.7M Trade date Dec 31, 2025 Filed date Jan 6, 2026
Kazimi A. J. Director, Officer, 10% Owner Other Form 4 events $3.91 7 $27 5.7M Dec 31, 2025 Jan 6, 2026
Krogulski Kenneth · Director Other Form 4 events $242
Price $3.91 Qty 62 Owned 297K Trade date Dec 31, 2025 Filed date Jan 6, 2026
Krogulski Kenneth Director Other Form 4 events $3.91 62 $242 297K Dec 31, 2025 Jan 6, 2026
15 of 199
15 of 199 Sign in to continue to older insider transactions.

Cumberland Pharmaceuticals Inc. (CPIX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Cumberland Pharmaceuticals Inc 5.7M
% of shares outstanding 40.1% Filing date Feb 9, 2024
Cumberland Pharmaceuticals Inc 5.7M 40.1% Feb 9, 2024
Kazimi A J 5.8M
% of shares outstanding 38.4% Filing date Feb 9, 2026
Kazimi A J 5.8M 38.4% Feb 9, 2026
Ikarian Capital, LLC 731K
% of shares outstanding 4.9% Filing date May 15, 2025
Ikarian Capital, LLC 731K 4.9% May 15, 2025
Integrated Core Strategies (us) LLC 599K
% of shares outstanding 4.0% Filing date Oct 30, 2025
Integrated Core Strategies (us) LLC 599K 4.0% Oct 30, 2025
4 of 4

Cumberland Pharmaceuticals Inc. (CPIX) ownership FAQ

Who owns CPIX?

28 reporting institutions disclosed CPIX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.